BofA Boosts AbbVie and J&J Price Targets on Growth and Pipeline Strength
BofA Boosts AbbVie and J&J Price Targets on Growth and Pipeline Strength AOL.com
Covered in this story
Analyst targets on AbbVie
- Citi: $244 → $260 by Jul 2027 · Neutral via GuruFocus
- UBS: $248 → $260 by Jul 2027 · Neutral via GuruFocus
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $ABBV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on AbbVie →Also covered by 1 other outlet
Dalsna Finance is currently tracking 50 stories mentioning AbbVie, the earliest published 15 May 2026.
Summary aggregated from AOL.com's public RSS feed. The full reporting belongs to AOL.com — please read it on their site.